Clene
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.About CLNN
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.
CEORobert Dee Etherington
CEORobert Dee Etherington
Employees79
Employees79
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2013
Founded2013
Employees79
Employees79
CLNN Key Statistics
Market cap78.21M
Market cap78.21M
Price-Earnings ratio-2.57
Price-Earnings ratio-2.57
Dividend yield—
Dividend yield—
Average volume88.33K
Average volume88.33K
High today$6.80
High today$6.80
Low today$6.47
Low today$6.47
Open price$6.47
Open price$6.47
Volume54.43K
Volume54.43K
52 Week high$13.50
52 Week high$13.50
52 Week low$2.28
52 Week low$2.28
Stock Snapshot
The current Clene(CLNN) stock price is $6.68, with a market capitalization of 78.21M. The stock trades at a price-to-earnings (P/E) ratio of -2.57.
On 2026-04-14, Clene(CLNN) stock traded between a low of $6.47 and a high of $6.80. Shares are currently priced at $6.68, which is +3.2% above the low and -1.8% below the high.
Clene(CLNN) shares are trading with a volume of 54.43K, against a daily average of 88.33K.
During the past year, Clene(CLNN) stock moved between $2.28 at its lowest and $13.50 at its peak.
During the past year, Clene(CLNN) stock moved between $2.28 at its lowest and $13.50 at its peak.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CLNN. This list is generated using Robinhood data, and it’s not a recommendation.